[
  {
    "ts": null,
    "headline": "Charles River Laboratories International, Inc. 2025 Q3 - Results - Earnings Call Presentation",
    "summary": "2025-11-08. The following slide deck was published by Charles River Laboratories International, Inc.",
    "url": "https://finnhub.io/api/news?id=ceb3fb7c59bb1778f494d6b0fac25de5617476c47c2dfcb8326c111da4c51a96",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1762625892,
      "headline": "Charles River Laboratories International, Inc. 2025 Q3 - Results - Earnings Call Presentation",
      "id": 137382283,
      "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
      "related": "CRL",
      "source": "SeekingAlpha",
      "summary": "2025-11-08. The following slide deck was published by Charles River Laboratories International, Inc.",
      "url": "https://finnhub.io/api/news?id=ceb3fb7c59bb1778f494d6b0fac25de5617476c47c2dfcb8326c111da4c51a96"
    }
  },
  {
    "ts": null,
    "headline": "Charles River Labs (CRL) Is Down 6.7% After Strategic Overhaul and $1B Buyback Plan Announced",
    "summary": "In the past week, Charles River Laboratories International announced a major strategic overhaul following third-quarter results, including plans to divest underperforming businesses totaling about 7% of revenue, ramping up cost-saving measures expected to save US$70 million annually by 2026, and adopting a new US$1 billion share repurchase authorization. This move signals an accelerated effort to sharpen business focus and enhance shareholder value amid continued demand challenges and...",
    "url": "https://finnhub.io/api/news?id=a7b975e7d8e09b4edb1b0dfee6a5f0bad4a0a716fdf24ed1af4417a8c1f56d8e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1762571491,
      "headline": "Charles River Labs (CRL) Is Down 6.7% After Strategic Overhaul and $1B Buyback Plan Announced",
      "id": 137378687,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CRL",
      "source": "Yahoo",
      "summary": "In the past week, Charles River Laboratories International announced a major strategic overhaul following third-quarter results, including plans to divest underperforming businesses totaling about 7% of revenue, ramping up cost-saving measures expected to save US$70 million annually by 2026, and adopting a new US$1 billion share repurchase authorization. This move signals an accelerated effort to sharpen business focus and enhance shareholder value amid continued demand challenges and...",
      "url": "https://finnhub.io/api/news?id=a7b975e7d8e09b4edb1b0dfee6a5f0bad4a0a716fdf24ed1af4417a8c1f56d8e"
    }
  }
]